08.17.20
In the courts, in the Administration and in drug maker initiatives, action on the Section 340B prescription drug discount program has heated up this summer.
08.14.20
The fragility of the primary healthcare system has become markedly apparent in the wake of the COVID-19 pandemic.
08.05.20
Primary healthcare plays an essential role in effectively addressing women’s unique health needs from puberty to reproduction through menopause and late life.
08.04.20
Prescription drug pricing is emerging as one of several healthcare issues that may become a focus of the presidential race as well as contested congressional races this fall.
07.16.20
Provider-payer partnerships are increasingly common and deliver key benefits.
07.09.20
As this decade begins, Americans are increasingly apprehensive about the privacy of their personal information.
06.23.20
Although delayed as a result of the COVID-19 public health emergency, there are persistent and ongoing efforts to reform the Medicare Part D benefit.
06.11.20
In a frequently asked question (FAQ) published late last week, the Health Resources and Services Administration (HRSA) indicated that patients of certain offsite outpatient clinics of hospitals that participate in the prescription drug pricing program established under Section 340B of the federal ...
02.26.20
In December 2019, BPC conducted a poll, asking voters which of the healthcare reform plans that the presidential candidates are putting forward represents their preferred approach.
The Trump administration has issued sweeping new Medicaid guidance, continuing its efforts to cap federal Medicaid funding.